Publications

Publications

Article
Kawazoe Y*, Katsuta T, Tanaka T, Nakamura Y, Sato S, Maeda M, Oda F, Fukuda H.
Prevalence of HPV Vaccine–Associated Symptoms in Unvaccinated Japanese Adolescents: A Descriptive Study from the VENUS Study Database.
Vaccine 2026; in press.
Sazawa M, Ishiguro C, Mimura W, Maeda M, Murata F, Fukuda H.
Impact of the resumption of proactive recommendation of HPV vaccination on HPV vaccination rates in Japan: An interrupted time series analysis based on the VENUS Study.
BMJ Public Health 2026; in press.
Ishiguro C*, Mimura W, Oda F, Maeda M, Fukuda H.
Population-Based Cohort Study Assessing the Effectiveness of Maternal BNT162b2/mRNA-1273 Vaccination Against Infant Coronavirus Disease 2019 Outcomes During Omicron Predominance: The VENUS Study .
Human Vaccines & Immunotherapeutics 2025; 21(1): 2585595.
Maeda M, Murata F, Fukuda H.
Effects of the introduction of a routine rotavirus vaccination program on vaccination coverage and factors in a Japanese municipality: The VENUS Study.
BMJ Public Health2025; 3: e002149.
Murata F, Maeda M, Fukuda H*.
Claims-based analysis of zoster vaccine effectiveness against incident herpes zoster: The VENUS Study.
JMA Journal 2025; 8(4): 1399-1402.
Sato S, Kawazoe Y, Murata F, Maeda M, Fukuda H.
Estimation of the adjusted risk difference for very rare events, large samples, and extreme exposure frequency: Application of Vaccine Effectiveness, Networking, and Universal Safety study.
Annals of Clinical Epidemiology2025; 7(2): 50-60.
Kim S, Maeda M, Murata F, Fukuda H*.
Effect of COVID-19 vaccination on the risk of developing post-COVID conditions: the VENUS study.
Vaccine 2024; 43(Pt 2): 126497.
Chikamochi T, Ishiguro C*, Mimura W, Maeda M, Murata F, Fukuda H.
Validation study of the claims-based algorithm using the International Classification of Diseases codes to identify patients with coronavirus disease in Japan from 2020 to 2022: The VENUS study.
Pharmacoepidemiology and Drug Safety 2024; in press.
Murata F, Maeda M, Fukuda H*.
Protective effects of 23-valent pneumococcal polysaccharide vaccination against mortality: The VENUS Study.
Open Forum Infectious Diseases 2024; 11(9): ofae530.
Mimura W, Ishiguro C, Maeda M, Murata F, Fukuda H.
Association between mRNA COVID-19 vaccine boosters and mortality in Japan: The VENUS Study.
Human Vaccines & Immunotherapeutics 2024; 20(1): 2350091.
1 2 3